Advanced Solid Tumors: NDI-219216 Treatment

We are testing a new drug called NDI-219216 in patients with advanced solid tumors, including those with specific genetic markers. The goal is to understand its safety and how it may work in these patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Paoli Calmettes
Marseille, France
Assistance Publique Hopitaux De Paris
Service d’oncologie médicale
Quinze-Vingts, France
Centre Hospitalier Universitaire De Poitiers
Pole régionale de cancérologie Service d'Oncologie Médicale
Saint-Benoît, France

Sponsor: Nimbus Wadjet Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.